Skip to content

Effect of wet cupping (Hijama) on cervical spondylosis.

Randomized Comparative Clinical Study to Evaluate the Efficacy and Safety of Hijama Bi l Shart on the Sites of Mankib and Kahil in the Management of Cervical Spondylotic Radiculopathy - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091576
Enrollment
60
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M953- Acquired deformity of neck Health Condition 2: M488- Other specified spondylopathies

Interventions

Intervention1: HIJAMA THERAPY (WET CUPPING THERAPY): GROUP 1 HIJAMA ON SITE OF MANKIB Intervention2: Group 2: Hijama therapy (wet cupping) on site of MANKIB will be carried out for 8 weeks (0 day, 14t

Sponsors

JAMIA HAMDARD University Moalajat dept
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of cervical spondylosis in the age-group of 30-60 years. 2.Patients of all genders 3.Patients with signs and symptoms of cervical spondylosis with radiculopathy and radiological evidences of cervical spondylosis in C3 TO C7 4.Cervical radiculopathy diagnosed by positive response to at least one of the four Upper Limb 5.Tension Tests with symptoms of cervical radiculopathy for less than 6 months 6.Pain intensity score of 30-60 mm on a 100-mm visual analog scale 7.Willingness to give informed consent

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Any history of cardiac, hepatic, renal insufficiency. 3.History of spinal whiplash injury OR fracture. 4.History of any spinal surgery. 5.Patients taking NSAIDs or corticosteroids (washout period NSAIDs 01 week Corticosteroids 6 weeks). 6.Known cases of any other disease of cervical spine like Ankylosing spondylitis, any Vascular lesions and Neoplasms. 7.Patients taking any non-pharmacological therapy for the same complaint in the past 4 weeks. (eg. Acupuncture, Hijama, physiotherapy). 8.Patients of bleeding disorders/ anaemia (Hb lower than 9 gm ). Patients taking Anti-coagulants. 9.HIV/AIDS, HCV and HBsAg positive patients. 10.Patients with uncontrolled Diabetes mellitus (HbA1C more than 7 percent) and hypertension (Systolic more 129 mm Hg, Diastolic more than 89 mm Hg). 11.Alcoholic patients, tobacco users.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy and safety of Hijamah bil-Shart on the sites Mankib and Kahil in the treatment of cervical spodylotic radiculopathy. To compare the effect of Hijamah bil Shart on the site Mankib with Hijamah bil Shart on Kahil in cervical radiculopathy. Timepoint: First evaluation on 0 day and the last will be on 70th day

Secondary

MeasureTime frame
To assess the effect of Hijamah bil Shart on quality of life in patients of cervical spondylotic radiculopathy. Timepoint: First evaluation on 0 day andthe last will be on 70th day

Countries

India

Contacts

Public ContactYasmeen Shamsi

Jamia Hamdard University

me.mariyakhan@gmail.com7701849171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026